Selected research
Industry Research
Medical Silk Fibroin Industry Research Report 2026
Market perspective
The global Medical Silk Fibroin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Silk Fibroin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Silk Fibroin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Silk Fibroin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Silk Fibroin include Chongqing Haifan Biochemical, Zhejiang Xingyue Biotechnology Co., Ltd, Suzhou Suhao Bio, Cathaya, Huzhou Xintiansi Bio-tech, Huzhou Aotesi Biochemical, Hanzhou Linran, Seiren Co. and Seidecosa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Silk Fibroin market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Silk Fibroin Market by Company
Chongqing Haifan Biochemical
Zhejiang Xingyue Biotechnology Co., Ltd
Suzhou Suhao Bio
Cathaya
Huzhou Xintiansi Bio-tech
Huzhou Aotesi Biochemical
Hanzhou Linran
Seiren Co.
Seidecosa
LANXESS
DSM
Dadilan
Caresilk
Medical Silk Fibroin Segment by Type
Silk Peptide
Silk Fibroin Powder
Silk Amino Acids
Medical Silk Fibroin Segment by Application
Plastic Surgery/Medical Beauty
Medical
Other
Medical Silk Fibroin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Silk Fibroin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Silk Fibroin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Silk Fibroin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Silk Fibroin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Silk Fibroin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Silk Fibroin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Silk Peptide
- Silk Fibroin Powder
- Silk Amino Acids
Applications
- Plastic Surgery/Medical Beauty
- Medical
- Other
Companies covered
- Chongqing Haifan Biochemical
- Zhejiang Xingyue Biotechnology Co., Ltd
- Suzhou Suhao Bio
- Cathaya
- Huzhou Xintiansi Bio-tech
- Huzhou Aotesi Biochemical
- Hanzhou Linran
- Seiren Co.
- Seidecosa
- LANXESS
- DSM
- Dadilan
- Caresilk
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Silk Fibroin Market Size (2021-2032)
- 2.2.2 Global Medical Silk Fibroin Sales (2021-2032)
- 2.2.3 Global Medical Silk Fibroin Market Average Price (2021-2032)
- 2.3 Medical Silk Fibroin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Silk Peptide
- 2.3.3 Silk Fibroin Powder
- 2.3.4 Silk Amino Acids
- 2.4 Medical Silk Fibroin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Plastic Surgery/Medical Beauty
- 2.4.3 Medical
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Silk Fibroin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Silk Fibroin Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Medical Silk Fibroin Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Silk Fibroin Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Silk Fibroin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Silk Fibroin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Silk Fibroin, Product Type & Application
- 3.8 Global Manufacturers of Medical Silk Fibroin, Established Date
- 3.9 Global Medical Silk Fibroin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chongqing Haifan Biochemical
- 4.1.1 Chongqing Haifan Biochemical Company Information
- 4.1.2 Chongqing Haifan Biochemical Business Overview
- 4.1.3 Chongqing Haifan Biochemical Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chongqing Haifan Biochemical Medical Silk Fibroin Product Portfolio
- 4.1.5 Chongqing Haifan Biochemical Recent Developments
- 4.2 Zhejiang Xingyue Biotechnology Co., Ltd
- 4.2.1 Zhejiang Xingyue Biotechnology Co., Ltd Company Information
- 4.2.2 Zhejiang Xingyue Biotechnology Co., Ltd Business Overview
- 4.2.3 Zhejiang Xingyue Biotechnology Co., Ltd Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhejiang Xingyue Biotechnology Co., Ltd Medical Silk Fibroin Product Portfolio
- 4.2.5 Zhejiang Xingyue Biotechnology Co., Ltd Recent Developments
- 4.3 Suzhou Suhao Bio
- 4.3.1 Suzhou Suhao Bio Company Information
- 4.3.2 Suzhou Suhao Bio Business Overview
- 4.3.3 Suzhou Suhao Bio Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Suzhou Suhao Bio Medical Silk Fibroin Product Portfolio
- 4.3.5 Suzhou Suhao Bio Recent Developments
- 4.4 Cathaya
- 4.4.1 Cathaya Company Information
- 4.4.2 Cathaya Business Overview
- 4.4.3 Cathaya Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cathaya Medical Silk Fibroin Product Portfolio
- 4.4.5 Cathaya Recent Developments
- 4.5 Huzhou Xintiansi Bio-tech
- 4.5.1 Huzhou Xintiansi Bio-tech Company Information
- 4.5.2 Huzhou Xintiansi Bio-tech Business Overview
- 4.5.3 Huzhou Xintiansi Bio-tech Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Huzhou Xintiansi Bio-tech Medical Silk Fibroin Product Portfolio
- 4.5.5 Huzhou Xintiansi Bio-tech Recent Developments
- 4.6 Huzhou Aotesi Biochemical
- 4.6.1 Huzhou Aotesi Biochemical Company Information
- 4.6.2 Huzhou Aotesi Biochemical Business Overview
- 4.6.3 Huzhou Aotesi Biochemical Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Huzhou Aotesi Biochemical Medical Silk Fibroin Product Portfolio
- 4.6.5 Huzhou Aotesi Biochemical Recent Developments
- 4.7 Hanzhou Linran
- 4.7.1 Hanzhou Linran Company Information
- 4.7.2 Hanzhou Linran Business Overview
- 4.7.3 Hanzhou Linran Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hanzhou Linran Medical Silk Fibroin Product Portfolio
- 4.7.5 Hanzhou Linran Recent Developments
- 4.8 Seiren Co.
- 4.8.1 Seiren Co. Company Information
- 4.8.2 Seiren Co. Business Overview
- 4.8.3 Seiren Co. Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Seiren Co. Medical Silk Fibroin Product Portfolio
- 4.8.5 Seiren Co. Recent Developments
- 4.9 Seidecosa
- 4.9.1 Seidecosa Company Information
- 4.9.2 Seidecosa Business Overview
- 4.9.3 Seidecosa Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Seidecosa Medical Silk Fibroin Product Portfolio
- 4.9.5 Seidecosa Recent Developments
- 4.10 LANXESS
- 4.10.1 LANXESS Company Information
- 4.10.2 LANXESS Business Overview
- 4.10.3 LANXESS Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 LANXESS Medical Silk Fibroin Product Portfolio
- 4.10.5 LANXESS Recent Developments
- 4.11 DSM
- 4.11.1 DSM Company Information
- 4.11.2 DSM Business Overview
- 4.11.3 DSM Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 DSM Medical Silk Fibroin Product Portfolio
- 4.11.5 DSM Recent Developments
- 4.12 Dadilan
- 4.12.1 Dadilan Company Information
- 4.12.2 Dadilan Business Overview
- 4.12.3 Dadilan Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Dadilan Medical Silk Fibroin Product Portfolio
- 4.12.5 Dadilan Recent Developments
- 4.13 Caresilk
- 4.13.1 Caresilk Company Information
- 4.13.2 Caresilk Business Overview
- 4.13.3 Caresilk Medical Silk Fibroin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Caresilk Medical Silk Fibroin Product Portfolio
- 4.13.5 Caresilk Recent Developments
5 Global Medical Silk Fibroin Market Scenario by Region
- 5.1 Global Medical Silk Fibroin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Silk Fibroin Sales by Region: 2021-2032
- 5.2.1 Global Medical Silk Fibroin Sales by Region: 2021-2026
- 5.2.2 Global Medical Silk Fibroin Sales by Region: 2027-2032
- 5.3 Global Medical Silk Fibroin Revenue by Region: 2021-2032
- 5.3.1 Global Medical Silk Fibroin Revenue by Region: 2021-2026
- 5.3.2 Global Medical Silk Fibroin Revenue by Region: 2027-2032
- 5.4 North America Medical Silk Fibroin Market Facts & Figures by Country
- 5.4.1 North America Medical Silk Fibroin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Silk Fibroin Sales by Country (2021-2032)
- 5.4.3 North America Medical Silk Fibroin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Silk Fibroin Market Facts & Figures by Country
- 5.5.1 Europe Medical Silk Fibroin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Silk Fibroin Sales by Country (2021-2032)
- 5.5.3 Europe Medical Silk Fibroin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Silk Fibroin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Silk Fibroin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Silk Fibroin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Silk Fibroin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Silk Fibroin Market Facts & Figures by Country
- 5.7.1 South America Medical Silk Fibroin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Silk Fibroin Sales by Country (2021-2032)
- 5.7.3 South America Medical Silk Fibroin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Silk Fibroin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Silk Fibroin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Silk Fibroin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Silk Fibroin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Silk Fibroin Sales by Type (2021-2032)
- 6.1.1 Global Medical Silk Fibroin Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Medical Silk Fibroin Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Silk Fibroin Revenue by Type (2021-2032)
- 6.2.1 Global Medical Silk Fibroin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Silk Fibroin Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Silk Fibroin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Silk Fibroin Sales by Application (2021-2032)
- 7.1.1 Global Medical Silk Fibroin Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Medical Silk Fibroin Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Silk Fibroin Revenue by Application (2021-2032)
- 7.2.1 Global Medical Silk Fibroin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Silk Fibroin Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Silk Fibroin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Silk Fibroin Value Chain Analysis
- 8.1.1 Medical Silk Fibroin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Silk Fibroin Production Mode & Process
- 8.2 Medical Silk Fibroin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Silk Fibroin Distributors
- 8.2.3 Medical Silk Fibroin Customers
9 Global Medical Silk Fibroin Analyzing Market Dynamics
- 9.1 Medical Silk Fibroin Industry Trends
- 9.2 Medical Silk Fibroin Industry Drivers
- 9.3 Medical Silk Fibroin Industry Opportunities and Challenges
- 9.4 Medical Silk Fibroin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst